The combination of interferon beta 1a (30 mcg IM weekly) and glatiramer acetate was not more effective on annualized relapse rate in multiple sclerosis compared to either treatment alone.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content